All Industries

IGC Pharma Releases Positive Interim Analysis Of Its Ongoing Phase 2 Trial In Alzheimer's Research

IGC Pharma, Inc. (IGC)

By Faith Ashmore, Benzinga As of 2023, the estimated number of Americans living with Alzheimer’s disease was 6.7 million. However, a lesser-known subsection of Alzheimer’s is Agitation in dementia from Alzheimer’s Disease (AAD). Recent research suggests that up to 76% of individuals with Alzheimer's also suffer from AAD. AAD is known to contribute to accelerated cognitive decline, increased burden on caregivers, higher rates of hospitalization and a greater need for medication – which collectively significantly diminish patients’ quality of life. Unfortunately, existing therapies for AAD carry black-box warnings, indicating the potential for serious adverse reactions that can result in death or serious injury. AAD has been associated with neuroinflammation, neurotransmitter imbalance and CB1 receptor dysfunctions. Research has also shown that AAD correlates with an upregulation of the inflammasome-3 and can contribute to neuroinflammation, ultimately leading to aggressive behavior. IGC Pharma (AMEX: IGC) is looking to provide treatment for millions of Americans struggling with ADD; its current drug, IGC-AD1, has been specifically designed to target the underlying causes of AAD and aims to fill the gap for a safe and effective therapy. Promising Clinical Studies For IGC-AD1 IGC-AD1 is undergoing extensive clinical trials to evaluate its effectiveness and safety in treating Alzheimer's disease. The phase two clinical trial, begun in 2023, encompasses 20 sites across the United States and Canada. With a target of 146 participants, this trial focuses on determining the efficacy of IGC-AD1 in alleviating agitation, a common symptom experienced by many Alzheimer's patients. The company has just announced the results of an interim analysis of its ongoing phase 2 trial. The main objective of the study is to evaluate the change in AAD over six weeks, utilizing the Cohen Mansfield Agitation Inventory (CMAI). The study showed that patients who were given IGC-AD1 had a more significant reduction in agitation levels compared to those who were given a placebo, with positive effects being observed as early as week two of the trial. At the six-week mark, the difference in agitation levels between the IGC-AD1 group and the placebo group was quite noticeable, with an effect size of 0.66 according to Cohen's d measure. The mean difference in the CMAI scores between the active treatment and placebo was -10.45, which indicates a meaningful contrast. Additionally, at the two-week mark, a secondary evaluation showed a positive effect size of 0.79 for IGC-AD1 compared to the placebo. "We are excited with the positive interim results from the Phase 2 trial of IGC-AD1 for agitation in dementia due to Alzheimer's disease. IGC-AD1’s interim results demonstrate a clinical and statistically significant reduction in agitation compared to placebo, suggesting a strong plausibility to address a substantial unmet medical need. This interim data validates IGC-AD1's potential as a transformative therapeutic option with a large market opportunity in Alzheimer's disease management,” said Ram Mukunda, CEO of IGC Pharma. “We are actively pursuing next steps, including with regulators, and remain committed to advancing IGC-AD1 toward commercialization. We foresee a medication that can help alleviate caregiver burden and family distress as managing Alzheimer’s patients, especially ones with agitation, can have a significant emotional toll on families. With IGC-AD1's promising clinical profile, we are confident in its ability, subject to further trials, to improve patient outcomes and drive shareholder value,” he added. In 2023, Alzheimer’s and other types of dementia were projected to cost the U.S. $345 billion. By 2050, these costs could rise to nearly $1 trillion. IGC-AD1 offers a glimmer of hope for the millions of individuals living with Alzheimer's disease, as well as their families. Featured photo by Ravi Patel on Unsplash IGC Pharma Inc. (IGC) is at the forefront of the fight against Alzheimer's disease, developing innovative solutions to address this devastating illness. The company's mission is to transform the landscape of Alzheimer's treatment with a robust pipeline of five promising drug candidates. IGC-AD1 and LMP target the hallmarks of Alzheimer's disease, including neuroinflammation, Aβ plaques, and neurofibrillary tangles. IGC-AD1 is currently undergoing a Phase 2b clinical trial for agitation in dementia associated with Alzheimer's (clinicaltrials.gov, CT05543681). TGR-63 disrupts the progression of Alzheimer's by targeting Aβ plaques. IGC-M3, currently in preclinical development, aims to inhibit the aggregation of Aβ plaques, potentially impacting early-stage Alzheimer's. IGC-1C, also in preclinical stages, targets tau protein and neurofibrillary tangles, representing a forward-thinking approach to Alzheimer's therapy. In addition to its drug development pipeline, IGC Pharma is actively leveraging Artificial Intelligence (AI) for Alzheimer's research. Their AI projects encompass various areas, including clinical trial optimization and early detection of Alzheimer's. These forward-looking statements are based largely on IGC Pharma’s expectations and are subject to several risks and uncertainties, certain of which are beyond IGC Pharma’s control. Actual results could differ materially from these forward-looking statements as a result of, among other factors, the Company’s failure or inability to commercialize one or more of the Company’s products or technologies, including the products or formulations described in this release, or failure to obtain regulatory approval for the products or formulations, where required, or government regulations affecting AI or the AI algorithms not working as intended or producing accurate predictions; general economic conditions that are less favorable than expected; the FDA’s general position regarding cannabis- and hemp-based products; and other factors, many of which are discussed in IGC Pharma’s U.S. Securities and Exchange Commission ("SEC") filings. IGC Pharma incorporates by reference the human trial disclosures and Risk Factors identified in its Annual Report on Form 10-K filed with the SEC on July 7, 2023, and Quarterly Report on Form 10-Q filed with the SEC on February 14, 2024, as if fully incorporated and restated herein. Considering these risks and uncertainties, there can be no assurance that the forward-looking information contained in this release will occur. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Rosalyn Christian rchristian@imsinvestorrelations.com Company Website https://igcpharma.com/

April 03, 2024 09:00 AM Eastern Daylight Time

Image

Bitdeer Creates First-Generation Bitcoin Mining Chip In Major Step To Becoming The First Fully Integrated Miner

Benzinga

by Austin DeNoce, Benzinga Bitdeer Technologies Group (NASDAQ: BTDR) just announced a significant milestone with implications for the entire Bitcoin mining industry by introducing its first-generation Bitcoin mining chip, the SEAL01, which is specifically designed for its new SEALMINER A1 mining rig. This launch represents a crucial development for Bitdeer, as it aims to position itself as the first fully integrated Bitcoin miner. Introducing Bitdeer’s SEAL01 Chip The SEAL01 chip is a result of Bitdeer’s collaboration with a leading semiconductor foundry, utilizing advanced 4-nanometer process technology. This innovation has led to a power efficiency of 18.1 J/TH. Jihan Wu, Bitdeer’s CEO, emphasized the chip’s role in enhancing the company’s mining capabilities as well as its alignment with the future demands of Bitcoin mining. It is also important to note that Mr. Wu was the co-founder of Bitmain, the world’s largest manufacturer of chips and hardware used in Bitcoin mining. The SEAL01 chip’s development underscores Bitdeer’s commitment to leading through technology and represents a major step toward the company becoming the only Bitcoin miner with complete control over its hardware supply chain. Bitdeer’s Vertical Integration Strategy Bitdeer’s strategy encompasses a move toward full vertical integration, where it owns the entire mining process from chip manufacturing to data center operations. This approach is aimed at improving efficiency, reducing costs and maintaining tighter control over production and overall operations. Unlike competitors that rely on third-party equipment, Bitdeer says its integration efforts will allow for a streamlined and optimized mining process, mitigating common industry challenges such as supply chain disruptions or lack of chip customization. Bitdeer’s venture into chips developed in-house for its mining operations directly addresses some of the big challenges faced by the broader mining industry, most notably the dependency on a limited number of external suppliers of application-specific integrated circuits (ASICs) uniquely designed for Bitcoin mining rigs. By manufacturing its own ASICs and mining equipment, Bitdeer can reduce operational costs, enhance supply chain reliability and adapt more swiftly to technological advancements that improve its mining efficiency. This self-reliance and enhanced efficiency could be a meaningful differentiator for Bitdeer heading into the upcoming Bitcoin halving where block rewards will be cut in half. Vertical Integration Is A Key Advantage Bitdeer's move toward vertical integration with the introduction of its SEAL01 chip contrasts with strategies employed by other miners like Riot Platforms Inc. (NASDAQ: RIOT) and CleanSpark Inc. (NASDAQ: CLSK). These companies are entirely dependent on third-party chipmakers and face the inevitable limitations of off-the-shelf solutions that lack customization and pricing transparency. Meanwhile, Marathon Digital Holdings Inc. (NASDAQ: MARA) recently became an investor in chip designer Auradine, but it currently does not appear to have any plans to directly involve itself in developing the technology. Mining efficiency is one of the biggest advantages for Bitcoin miners, and without integrating chip development into their operations, miners will likely struggle to achieve the same level of capital efficiency as Bitdeer does. The reliance of these and other miners on third parties for a critical element of the Bitcoin mining operational inputs also introduces counterparty risk that could leave them vulnerable to supply-chain disruptions and other inefficiencies. Bitdeer’s approach, emphasizing in-house chip and mining machine development, showcases a strategic pivot toward self-sufficiency, opening the door to significant advantages in customization, cost reduction and overall operational efficiency. This method also seems to favorably position Bitdeer ahead of the halving, potentially inspiring the industry to adopt a more integrated strategy. Implications For Bitdeer’s Growth The introduction of the SEAL01 chip and Bitdeer's shift toward vertical integration are both critical elements to Bitdeer’s growth. In February, Bitdeer said it saw a 64% year-over-year increase in total bitcoin mined, but after the Bitcoin halving later this year, mining rewards will be cut in half, meaning advancements in efficiency could become a deciding factor in which miners stay afloat. Once Bitdeer’s new mining chips are integrated into its machines, the company is likely to see a notable uptick in efficiency to keep its growth moving in the right direction. Ultimately, Bitdeer’s move reflects a prudent strategy that could redefine industry emphasis on in-house technology development and encourage other companies to consider greater integration to mitigate risks and improve their own efficiency. Featured photo by Dmytro Demidko on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

April 03, 2024 08:45 AM Eastern Daylight Time

Image

KangaMoon (KANG) Surpasses $3.7M Milestone, Myro Surges 34% Can PepeFork Keep Up?

Kangamoon

Myro (MYRO) has recently made a major price jump, where throughout the span of a single week, it increased in value by 34%. Moreover, the KangaMoon (KANG) presale-stage project raised over $3.7 million, and could soon raise even over $4.5 million. As a result, sentiment is massive surrounding these two cryptocurrencies, but many are curious if PepeFork (PORK) can keep up. To see if this will be the case, we will go over all three individually, and determine which is the best cryptocurrency to buy today. Myro (MYRO) Grows 34% – Price to Spike to $0.471 by End of Q4 Myro (MYRO) gas experienced a substantial price climb which has resulted in a monumental level of interest towards the crypto from investors and traders. Moreover, during the past month, the Myro price saw a price increase of 102.2%, and within a single week its up 34%. Just during the previous week, the Myro crypto experienced a jump from a low point of $0.2286 to a maximum value at $0.3647, signifying a 34% price jump. As a result, sentiment on its future is massive, and according to the Myro price prediction, it can end 2024 at $0.471. KangaMoon (KANG) to Spike 5,000% Fueled by Vast Ecosystem KangaMoon (KANG) is one of the latest projects to enter the industry and it has already seen a significant price upswing, alongside a rapid presale momentum. Specifically, this is a project which introduces Play-to-Earn (P2E) elements alongside a community-driven approach, and Social-Fi features. Anyone can control a KangaMoon character, where they can engage in battles or attend tournaments. By doing so,they are rewarded KANG tokens or rare NFTs. These can later-on get sold in the marketplace, while other NFTs can be bought or traded. During Stage 4, KANG has increased in value to $0.0014, marking a 180% jump from its initial price. In addition, its raised $3.7 million and can hit $4 million by next week. As a result, sentiment is bullish on its future and analysts project a 5,000% increase at launch. These aspects position KANG as one of the best cryptocurrency to buy today. PepeFork (PORK) to Initiate Recovery Despite 50.8% Dip PepeFork (PORK) has seen a negative price trend which has resulted in a significant price decrease. Within the past two weeks, the PepeFork price has decreased by 50.8%. Moreover, just within the span of a single week, the price of the PepeFork crypto is down 32.6%, and now, it needs to regain the attention from bulls to get back up in value. The monthly high for PORK was at $0.0000007057, while the monthly low was at $0.0000002413. However, its still 254.37% up from its all-time low two months ago, which does showcase some signs of a potential recovery. According to the PepeFork price prediction, it can end 2024 at $0.00000094. Summary While both Myro and KangaMoon have showcased impressive performance, PepeFork has seen a price dip which resulted in bearish market sentiment. As a result, those looking to diversify their holdings and get massive ROI are now eyeing KANG, as it can spike 5,000% at launch, making it one of the best cryptos to invest in. Discover the Exciting Opportunities of the KangaMoon (KANG) Presale Today! Website: https://KangaMoon.com/ Join Our Telegram Community: https://t.me/KangaMoonofficial Integrating GameFi and Play To EarnEmbark on your quest for glory. Assemble your champions, engage in epic battles or bet on your favorite fighters to earn $KANG tokens and exclusive rewards. Gain control of rare NFTs, unlock exclusive content and build alliances with fellow gamers as you ascend the ranks and leaderboards. Disclaimer: The following disclaimer is important to read and understand before engaging with Kangamoon, a play-to-earn meme coin. By accessing or participating in any activities related to Kangamoon, you acknowledge and accept the terms outlined below: 1 No Financial Advice: This whitepaper and any associated content do not constitute financial advice, investment recommendations, or solicitation to purchase Kangamoon tokens. The information provided is for informational purposes only. It is your responsibility to conduct thorough research and seek professional advice before making any financial decisions. 2 Volatility and Risks: Cryptocurrencies, including Kangamoon, are volatile and subject to significant price fluctuations. Investing in or holding Kangamoon tokens involves substantial risks, including the possibility of total loss. Past performance is not indicative of future results. 3 Regulatory Compliance: The regulatory environment surrounding cryptocurrencies is evolving and varies across jurisdictions. It is your responsibility to ensure compliance with applicable laws and regulations in your country or region before engaging with Kangamoon. 4 Uncertain Market: The market for meme coins and play-to-earn platforms is highly speculative and subject to rapid changes. There is no guarantee of market demand, liquidity, or utility for Kangamoon tokens. Token values may fluctuate drastically and may not reflect the intrinsic value of the project. By continuing to engage with Kangamoon, you acknowledge and accept the risks and limitations outlined in this disclaimer. You should only participate if you fully understand and are willing to assume these risks. Contact Details Kangamoon marketing@kangamoon.com Company Website https://kangamoon.com/

April 03, 2024 07:39 AM Central Daylight Time

Image

Green Lantern Solar Announces Promotion of Alan Pratt to Vice President of Operations

Green Lantern Solar

Green Lantern Solar, an innovative and trusted renewable energy developer, today announced the promotion of Alan Pratt to the position of Vice President of Operations. With a proven track record as Green Lantern Solar’s Director of Operations for 10 years and deep experience in EPC roles before then, Alan brings exceptional leadership qualities and a steadfast commitment to the company’s mission. In his new capacity, Alan will take charge of Green Lantern Solar’s Engineering Team and other critical areas such as the Operations and Maintenance (O&M) division. “Alan’s exemplary leadership and deep-rooted dedication to Green Lantern Solar have consistently propelled our organization forward,” said Scott Buckley, President of Green Lantern Solar. “We are confident that under his guidance, our Engineering and O&M departments will continue to excel and contribute significantly to our strategic objectives.” Alan’s promotion coincides with the retirement of Peter Edlund, who has been an integral part of Green Lantern Solar’s success for nearly a decade. Peter’s contributions have been instrumental in building a strong company and shaping the company’s growth. “Peter’s retirement marks a significant milestone for Green Lantern Solar,” Buckley continued. “His expertise, dedication and leadership have made a lasting impact on our company and its trajectory. We extend our heartfelt appreciation to Peter for his years of dedicated service.” During his tenure, Peter led Green Lantern Solar’s Engineering, Procurement and Construction (EPC) division and the O&M division. He oversaw the successful completion of more than 125 community-scale solar projects and earned industry recognition, including the 2023 Solar Builder Community Solar Project of the Year. “We express our deepest gratitude to Peter for his invaluable contributions,” Buckley added. “We wish him every success and fulfillment in his well-deserved retirement — or, as he likes to call it, ‘graduation.’ His hard work and good humor will be missed.” About Green Lantern Solar Green Lantern Solar is a vertically integrated regional renewable energy development company emphasizing the development of community solar projects and commercial solar solutions for municipal, education, healthcare and government entities. Green Lantern works with landowners to revitalize and re-develop low-value sites such as brownfields, landfills, quarries/pits/extraction sites and other challenging real estate. The company currently provides a full suite of services: development, financing, construction and operations, maintenance and asset management. For more information, https://www.greenlanternsolar.com/, on LinkedIn and @GrnLntrnSolar on Twitter. Contact Details Wilkinson + Associates for Green Lantern Solar Leah Wilkinson +1 703-307-3964 leah@wilkinson.associates Company Website https://www.greenlanternsolar.com/

April 03, 2024 08:38 AM Eastern Daylight Time

Sharps Technology's Global Expansion: Achieving Key Milestones To Strengthen Market Position

Benzinga

by Kenneth Adams, Benzinga Sharps Technology, Inc. (NASDAQ: STSS), an innovative medical device and pharmaceutical packaging company, and Roncadelle Operations, an Italian-based driving force in the development of novel medical drug delivery devices announced a collaboration aimed at transforming the landscape of drug delivery systems worldwide. This strategic partnership encompasses a series of agreements and initiatives designed to enhance market access, drive collaboration and innovation and promote patient safety worldwide. The partnership commenced in mid-January with the signing of a Letter of Intent (LOI) between Sharps Technology and Roncadelle Operations to enter into a sales and marketing agreement that would enable Sharps and Roncadelle to cooperatively sell and distribute each other’s products to their respective areas of influence and expand Sharps’ American-based product market into Europe, the Middle East, Africa and the Asia-Pacific region. By mid-February Sharps began working with Owens & Minor, a leading global healthcare logistics supplier, to establish a 3PL and distribution network across North and South America for both the Sharps and Roncadelle lines of smart disposable safety syringes. “We are excited about this opportunity to collaborate with Roncadelle, a premier manufacturer of smart safety syringes and a leader in the development of drug delivery systems, to expand both our solution offerings in the U.S. and our reach into the world market,” commented Sharps Technology CEO Robert Hayes. “This agreement is very beneficial for both of our companies.” Sharps Technology specializes in the development and manufacturing of innovative drug delivery systems. The company’s Securegard and Sologard product lines focus on low-waste and ultra-low waste syringe technologies that incorporate both active safety features and World Health Organization-accredited reuse prevention measures. Roncadelle’s SafeR Retractable Safety Syringe and needles offer a passive safety system with both auto-disable and reuse prevention features. “Sharing our product portfolio gives our healthcare customers, from large pharmaceutical companies to startup biologics, access to a broad range of solutions and price points to match even their most challenging requirements. This will open up a completely new level of service to the market,” states Ben Scheu, Sharps’ Senior Director of Sales. Sharps reports that the synergy between Sharps and Roncadelle will bring together more than 30 established distribution points with Sharps’ new Owens & Minor partnerships to deliver products to the world healthcare market that stand for simplicity of use and are unparalleled in safety and patient protection, setting new global standards to safeguard people from infection and disease. The business alliance additionally potentially creates a very important player in advancing syringe market opportunities through the development of unique technologies such as prefilled syringes, needle guard systems, auto-injectors and injector pen devices. “It is exciting to see how well our companies complement each other and how we can leverage our combined relationships, expertise, and resources to build out our distribution network, enhance syringe safety around the world, and introduce novel drug delivery solutions to the healthcare industry,” said Robert Hayes, Sharps CEO. On February 21, 2024, Sharps Technology. announced that it was preparing to make the first shipment of its 1mL and 3mL Securegard smart safety syringe line to the Latin American healthcare market. Tapping into the growing interest in safety syringe technology in Latin America, the collaboration will make the Securegard syringe line available to hospitals, pharmacies and direct points of sale and will give healthcare networks access to utilizing the technology and firsthand experience with its real-world benefits. “We are building strategic partnerships within the entire Latin American distribution network to support region-wide efforts to improve medical safety and healthcare outcomes. While implementing wide-scale change can be challenging, we are well positioned to introduce Securegard to healthcare agencies and facilities across the region,” comments Robert Hayes, Sharps Technology CEO. “Based on prior studies, we are confident that once healthcare practitioners use Securegard syringes, they will want to continue to use them in their practice, leading to ongoing purchase orders.” Securegard syringes provide clinicians with an ultra-low waste drug delivery technology that incorporates active safety features as well as World Health Organization-accredited reuse prevention measures. These features maximize the amount of drug therapy that is available to patients while both protecting frontline healthcare workers from life-threatening needle stick injuries and protecting the public from the dangers of needle reuse. Securegard syringes offer a promising drug delivery solution for healthcare markets, facilities and providers by incorporating safety and reuse prevention features into their design. Moreover, the use of ultra-low waste syringe technology ensures that the maximum number of doses of needed drug therapies can be made available to the people who depend on them. On March 7, 2024, Sharps Technology and Roncadelle Operations signed a sales and distribution agreement to cooperatively sell and distribute each other’s products to their respective areas of influence. The agreement lays the groundwork for further collaboration between Sharps and Roncadelle to develop and manufacture next-generation drug delivery products. “We believe that this is just the beginning of Sharps’ collaboration with Roncadelle. It expands our footprint as a premier manufacturer and a distributor of smart safety syringes as well as a collaborative leader in the development of drug delivery systems for the world market,” commented Sharps Technology CEO Robert Hayes. “Sharing our product portfolio gives healthcare customers one-stop access to a broad range of delivery solutions and price points to match their needs and strictest requirements.” As part of the cooperative agreement, Sharps and Roncadelle intend to collaborate on the development of new drug delivery products. The need for innovative injection solutions is expected to grow over the next several years as injectables are the first choice for therapies as diverse as vaccines, biologics, weight loss and maintenance, ophthalmics, gene therapies and diabetes management. The collaboration between Sharps and Roncadelle potentially creates a very important player in advancing these market opportunities through the development of technologies such as prefilled syringes, needle guard systems, auto-injectors and injector pen devices. In light of the recent FDA safety communications concerning the use of syringes manufactured in China, the company believes that the market for safer syringes produced in the U.S. and Europe will grow at an accelerated rate. Featured photo by LookerStudio on Shutterstock. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

April 03, 2024 08:30 AM Eastern Daylight Time

Image

Reflection Analytics’ Reflect Platform Named to the Prestigious WealthTech100 Ranking of the World’s Most Innovative Technology Providers

Reflection Analytics

Reflection Analytics, a technology company delivering ESG investment evaluation, reporting and advisory services, announced today that its Reflect software platform has been named to the prestigious WealthTech100 list of the world’s most innovative technology providers that are transforming the operations of investment firms, private banks and financial advisors. Reflect is the first and only platform for investor-focused ESG analysis, serving asset managers, financial advisors and investors/institutions across six key areas: advisory, due diligence, compliance, portfolio management, auditing and reporting. Reflect’s inclusion on the WealthTech 100 comes within Reflect’s first year as a compliance tool. “This recognition by the WealthTech100 is validation for Reflect,” said Jason Britton, founder and chief executive officer of Reflection Analytics. “The Names Rule requires funds generally aligned with ESG terms to have a minimum of 80 percent of its holding invested in what the average investor would consider the plain English meaning of those terms. Reflect is basically a lie detector that investors and fund managers can use to determine whether funds comply with that common-sense, truth-in-advertising standard.” Launched today by FinTech Global, a specialist research firm, The WealthTech100 shines a spotlight on the WealthTech companies that every stakeholder in the wealth management industry should know about. The finalists were picked by a panel of analysts and industry experts, and judges were tasked with reviewing a list of more than 1,300 companies, with FinTech Global providing detailed information on each company to aid the decision process. To make the list, the panel looked for companies that are helping address some of the biggest challenges and opportunities within wealth management. The list highlights the leading companies in areas such as client acquisition, financial planning, portfolio management and digital brokerage. "As the great wealth transfer takes place, wealth management firms are seeking ways to update their operations to meet the demands of future customers,” said FinTech Global director Richard Sachar. “While older generations preferred a human-touch, younger generations place quick, simple and digital processes at the top of their requirements. The WealthTech100 list provides senior decision-makers with a guide on the best vendors in the market and practical examples of how the latest AI advancements are transforming the investment industry.” Launched just two months after the SEC expanded Rule 35d-1, the “Names Rule,” to include ESG terms, Reflect is the market’s only “Names Rule"-compliant software, providing an investor-focused rating that scores companies across 250 data points in 18 ESG sub-themes while also offering asset managers a portfolio management tool to ensure continuous compliance. Under the SEC’s expanded rule, asset managers have 24 months from September 2023 to begin reporting on their alignment, demonstrating that 80% of their investments are in securities that reflect the terms in their name, or risk regulatory fines and fees. Unlike other ESG rating companies, which focus on only financial materiality and from the corporation’s management perspective, Reflect assesses companies from the perspective of an investor’s understanding and reasonable expectations. Beyond its use as a compliance tool, Reflect is designed to support values-based investing. The Reflect platform allows advisors, investors and institutions to review portfolios based on ESG components that are most important to them while also identifying types of companies to avoid, such as those associated with weapons or alcohol. After analyzing an investment portfolio, Reflect provides a real-time, percentage-match score, rating investments across 18 sub-themes ranging from “not aligned” to “strongly aligned.” Reflect can also weigh an existing portfolio against a curated list of investments, allowing individuals and institutions to compare assets via a side-by-side analysis. A full list of the WealthTech100 and detailed information about each company is available to download for free at www.WealthTech100.com. About Reflection Analytics Reflection Analytics’ patent-pending software—Reflect—is the only ESG ratings tool designed to serve asset managers, financial advisors and investors/institutions across six key areas: advisory, due diligence, compliance, portfolio management, auditing and reporting. Unlike other ESG software, which are reliant on rating methodologies rooted in the corporate perspective, Reflect analyzes 250 data points from an investor-focused viewpoint. As the industry’s only “Names Rule-compliant tool,” Reflect helps portfolio managers meet new compliance standards, with the SEC’s expansion of the “Names Rule” to include ESG funds taking effect in less than two years. Reflect maintains comprehensive self-reported and third-party data on 6,500 companies, or 98% of the global market cap. For more information, visit: www.reflectvalues.com. Contact Details Peter Page ppage@vocatusllc.com Company Website https://www.reflectvalues.com/

April 03, 2024 08:30 AM Eastern Daylight Time

BestGrowthStocks.Com Issues Comprehensive Evaluation of XTI Aerospace, Inc.

XTI Aerospace, Inc.

Best Growth Stocks, a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing exclusive ai-assisted research recently issued a comprehensive evaluation of XTI Aerospace, Inc. the parent company of XTI Aircraft Company, an aviation business based near Denver, Colorado. XTI Aerospace, Inc. (NASDAQ: XTIA) has recently caught the attention of many investors following the announcement that the company plans to advance the revolutionary TriFan 600, a disruptive vertical takeoff and landing (VTOL) aircraft with conditional pre-orders. Best Growth Stock's full report breaks through the noise and offers an extensive comprehensive evaluation of XTI Aerospace, Inc.'s potential catalysts, current estimated share structure, cash position, recent developments, and how they relate to potential future catalysts, financial performance, and much more. Access this full analysis free: https://bestgrowthstocks.com/access-xtia-analysis/ (If you cannot click the link above, copy and paste to your browser may be required). About XTI Aerospace, Inc. XTI Aerospace is the parent company of XTI Aircraft Company (XTIAircraft.com), an aviation business based near Denver, Colorado, currently developing the TriFan 600, a fixed-wing business aircraft designed to have the vertical takeoff and landing (VTOL) capability of a helicopter, speeds of 345 mph and a range of 700 miles, creating an entirely new category – the vertical lift crossover airplane (VLCA). The Company is guided by a leadership team with decades of business experience, deep aviation industry expertise, and a proven track record successfully bringing new aircraft to market, including participation on teams that played a role in taking over 40 aircraft through FAA certification. Additionally, the Inpixon business unit (inpixon.com) of XTI Aerospace is a leader in RTLS technology with customers around the world who use the Company's location intelligence solutions in factories and other industrial facilities to help optimize operations, increase productivity, and enhance safety. For more information about XTI Aerospace, please visit XTIAerospace.com. About Best Growth Stocks Best Growth Stocks is a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing our exclusive ai-assisted research. BGS is also a financial news provider, focused on giving investors direct access to CEOs of promising, publicly-traded companies, and market experts. Our CEO interviews aim to answer the questions that rest on the minds of current and future shareholders. This is not to be construed as financial advice. Please consult with a licensed financial advisor before making any investment decisions. Contact Details Best Growth Stocks Senior Editor: Steve Macalbry Editor@BestGrowthStocks.com

April 03, 2024 08:27 AM Eastern Daylight Time

Crypto Lending 101: Making The Most Of Your Idle Digital Assets

Ledn

By Austin DeNoce, Benzinga As the cryptocurrency market evolves, so, too, do the financial services built around it. Cryptocurrency owners can now even generate passive income through lending and securing loans using their cryptocurrency assets as collateral. However, in an industry notorious for bankruptcies and fraud, carefully navigating the complexities inherent to such financial services is extremely important. While there is no shortage of lucrative opportunities in crypto, balancing those opportunities with the safety of your assets should always be a top priority. Picking the right services or platforms is a major step in the right direction, but it’s also useful to familiarize yourself with the financial products you’re considering so you can make the most informed decision that doesn’t jeopardize the safety of your assets. What Is Crypto Lending? Crypto lending falls into two main categories: earning interest by lending out your crypto and using your crypto as collateral for loans. The former allows crypto holders to earn attractive yields on their assets, ranging from a few basis points to double-digit annual returns in many cases. The latter allows crypto holders access to liquidity via loans at competitive rates without selling their cryptocurrency assets and creating a taxable event. Essentially, crypto lending platforms allow you to deposit your crypto assets to earn additional returns over time from those borrowing your funds, or you can be on the other side of the transaction, getting access to dollars or another currency without selling your crypto, which can provide a lot of flexibility. Crypto Savings Accounts As one example, crypto lending platforms like Ledn.io offer Growth Accounts that enable cryptocurrency holders to earn up to 11% annual percentage yield (APY) on their BTC, ETH, USDC or USDT holdings (disclaimer: these products are not available in Canada or the USA). However, as mentioned previously, returns are just one part of the equation. The safety of your funds is also paramount, so Ledn prioritizes transparency and the selection of what it considers reliable digital assets, which isn’t always the case for other lending platforms in this space. Lending your assets generally opens you up to credit risk, which can quickly make attractive returns meaningless if things go south. Luckily, customers on platforms like Ledn can enjoy the peace of mind that comes with the company’s strict risk management policies, including a single-asset ring-fenced approach for its Growth Accounts, and its monthly Open Book Reports that offer insights into how the interest for its savings or Growth Accounts is generated. Crypto-Backed Loans Crypto loans are typically categorized into Centralized Finance (CeFi) and Decentralized Finance (DeFi) loans. CeFi loans are managed by centralized platforms like Ledn.io, which oversees the lending process, including interest rates and risk management. DeFi loans, on the other hand, operate on blockchain platforms through smart contracts without a central authority. Each type offers distinct advantages and risks, with CeFi providing a more regulated environment and DeFi offering more autonomy and potential for higher returns but also more complexity. Ledn.io provides crypto-backed loans that give you access to funds without selling your Bitcoin or Ethereum. You can use BTC or ETH as collateral to receive 50% loan-to-value loans, typically within 24 hours, with the freedom to repay anytime penalty-free. Loans are offered in USD, USDC or your local currency and start at a 12.4% annual interest rate. If you choose to go with a Ledn Custodied Loan, your collateral is held in custody with qualified custodians and/or banks and is not lent out to generate interest. Ledn.io’s crypto-backed loans require a minimum of $1,000 in BTC or ETH as collateral. To reassure customers, Ledn says it is the first digital asset lending platform to complete a Proof-of-Reserves Attestation where customers can confirm balances themselves using a hashed ID. Exploring The Opportunities For Your Crypto If you are interested in putting your crypto to work or exploring the various financial opportunities your crypto assets can provide, Ledn.io offers a compelling choice. Whether through earning passive income or securing loans, your idle crypto assets can open doors previously limited to the legacy financial system. With up to 11% APY on deposits, transparent operations and robust risk-mitigating measures, Ledn says it is at the forefront of making crypto lending both profitable and secure. Its emphasis on customer control, security and an open approach to risk management potentially makes it a valuable partner in the crypto lending space. Begin your crypto lending journey with Ledn.io by clicking here! Featured photo by Traxer on Unsplash. Ledn builds innovative financial products with a mission to make generational wealth more accessible through digital assets. The company issued Canada’s first bitcoin-backed loan in 2018 and has issued nearly $5B loans since. Ledn is proud to help clients in over 130 countries access credit and savings products to grow their digital wealth. For more information, visit ledn.io. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Adam Reeds adam@ledn.io Company Website https://ledn.io/

April 03, 2024 08:25 AM Eastern Daylight Time

Image

Novidea Appoints Jeff Heine as Chief Revenue Officer

Novidea

Novidea, creator of the cloud-based, data-driven enterprise insurance management platform for brokers, agents, MGAs/MGUs, carriers, and wholesalers, has added Jeff Heine as chief revenue officer (CRO). Heine will be instrumental in driving global revenue and further aligning Novidea’s sales, marketing, and other revenue-focused functions to achieve the company’s business and growth objectives. Heine brings 20 years of Property and Casualty (P&C) insurance industry expertise to the role. Most recently, he served as CRO at Betterview, a remote property intelligence platform that turns data into actionable insights for P&C insurance carriers (acquired by Nearmap). Before that, Heine was CRO at Groundspeed Analytics, an AI-powered ingestion and data solution for the commercial P&C industry (acquired by Insurance Quantified). Heine has other related experience including Guidewire Software and Adsensa (now Coupa Software). "Jeff is an accomplished CRO in the Insurtech market with proven experience building high-performing global teams, establishing scalable processes, and leading growth initiatives. His talents will be invaluable as Novidea continues to scale up its global operations,” said Roi Agababa, CEO of Novidea. “Jeff joins our strong leadership team to help guide the company's journey and to continue to deliver industry-leading innovation, quality, and value to our customers worldwide.” With the addition of Heine, Novidea further strengthens its global leadership team, adding to the recent strategic hires of Erez Nissim as chief technology officer (CTO), Eran Ben Ezer as chief financial officer (CFO), and Yaniv Cohen as chief customer officer (CCO). By assembling a team of exceptional talent, Novidea reinforces its position as a top innovator in the global insurance technology landscape. “I’ve spent the last two decades helping insurance brokers and carriers better assess and price risk, manage core processes and systems, and create efficiencies. I came to Novidea because I wanted to help reduce the friction brokers and carriers still experience in the insurance placement process and contribute to an innovative fast-growing company,” Heine said. “I look forward to helping our customers grow their businesses and create a better insurance experience for policyholders. I am excited to join a company that has the right team and technology to make insurance more accessible to businesses and consumers through better use of data and insights." About Novidea Novidea is the leading Insurtech provider of a cloud-native, data-driven insurance management system. With its open API architecture, Novidea enables brokers, agents, MGAs, and carriers to modernize and manage the customer journey end-to-end and drive growth across the entire insurance distribution lifecycle. Novidea's streamlined and automated platform fully integrates front, middle, and back offices. The Novidea platform boosts operational efficiency while providing a seamless digital experience for team members and customers alike. Insurance businesses benefit from a 360-degree view of customers and policies and can access data and actionable insights anytime, anywhere, and on any device. Novidea supports more than 100 customers across 22 countries. Contact Details Michelle Barry +1 603-809-2748 Michelle.barry@chameleon.co Company Website https://novidea.com/

April 03, 2024 08:00 AM Eastern Daylight Time

1 ... 295 296 297 298 299 ... 3753

Back